See Which Of The Latest 13F Filers Holds MRK

Aggregate 13F filings for the 06/30/2025 reporting period indicate that institutional investors collectively reduced their long positions in Merck & Co Inc (MRK) by 1.20%, or 289,192 shares, between Q1 and Q2 2025. This aggregate reduction, with total holdings dropping from 24.19 million to 23.90 million shares across 507 funds, suggests a slight net divestment and a cautious shift in broad institutional sentiment towards MRK, despite some individual funds increasing their stakes.

Analysis

An analysis of 13F filings for the period ending June 30, 2025, reveals a net reduction in institutional ownership of Merck & Co Inc (MRK). Across a pool of 507 funds, aggregate holdings decreased by 1.20%, or 289,192 shares, from 24.19 million to 23.90 million. This aggregate trend indicates a mild cooling of institutional sentiment. A closer look at a recent batch of 27 filers shows a divided picture, with eight funds decreasing their positions and seven increasing them. Notably, the reductions were substantial, with firms like BDF Gestion and CX Institutional cutting their stakes by 45,436 and 18,031 shares, respectively, while one fund, Marshall & Sullivan Inc. WA, exited its position entirely. While the data only captures long positions and is backward-looking, the net selling pressure from this group of reporting institutions suggests a cautious re-evaluation of MRK holdings during the second quarter.

Key Decisions for Investors

• Investors should note the 1.20% aggregate decline in institutional holdings as a potential signal of a cautious shift in sentiment, prompting a review of their own thesis for holding Merck.
• Given the concentration of selling among a few key funds, it may be prudent to investigate if firm-specific or broader sector-rotation factors drove these large divestments.